<DOC>
	<DOCNO>NCT02850003</DOCNO>
	<brief_summary>Study design assess safety plasma PK tretinoin metabolite topically apply IDP-120 gel .</brief_summary>
	<brief_title>Absorption Systematic Pharmacokinetics Topically Applied IDP-120 Gel</brief_title>
	<detailed_description>An Open-label study design assess safety plasma PK tretinoin metabolite topically apply IDP-120 gel .</detailed_description>
	<criteria>Key Male female age 9 &lt; 17 ( 16 year 11 month ) Written verbal informed consent must obtain . Subjects less age consent must sign assent study parent legal guardian must sign informed consent . Subject must score 3 ( moderate ) 4 ( severe ) Evaluator 's Global Severity assessment . Subject facial acne inflammatory lesion count less 20 40 . Subject facial acne noninflammatory lesion count less 20 100 . Key Use investigational drug device within 30 day enrollment , previous participation research study IDP120 Gel , participation research study concurrent study . Any dermatological condition face could interfere clinical evaluation acne conglobate , acne fulminans , secondary acne , perioral dermatitis , clinically significant rosacea , gramnegative folliculitis . Any underlying disease dermatological condition face require use interfere topical systemic therapy make evaluation lesion count inconclusive . Subjects facial beard mustache could interfere study assessment Subjects 2 facial nodule .</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>